Navigation Links
Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
Date:8/29/2013

imes, as well as planned interaction with research analysts and institutional investors)
  • Corporate Governance information
  • About Eli Lilly and Company
    Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers — through medicines and information — for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

    C-LLY

    FOR MORE INFORMATION, CONTACT:

    Alex Kepnes
    Humana Corporate Communications 
    502-580-2990
    akepnes@humana.com  

    Kelley Murphy
    Eli Lilly and Company
    317-701-4007
    murphy_kelley@lilly.com   

    (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

    (Logo: http://photos.prnewswire.com/prnh/20130829/DE70165LOGO )


    '/>"/>
    SOURCE Eli Lilly and Company; Humana Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Comprehensive Care Corporation Announces New Medicare Contract with Humana Health Plan of California, Inc.
    2. Dr. Marschall S. Runge Elected to Lilly Board of Directors
    3. Lilly Reports Second-Quarter 2013 Results
    4. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
    5. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
    6. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
    7. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
    8. Lilly Declares Third-Quarter 2013 Dividend
    9. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
    10. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
    11. Lilly Statement on Indiana Biosciences Research Institute
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... und MARSEILLE , Frankreich, ... , Weltweite Exklusivlizenz der Universität ... die Entwicklung von Tests auf SF3B1-Mutationen, einschließlich ... Neuer Test weist Mutationen des SF3B1-Gens ... Syndromen) einen günstigen Krankheitsverlauf vermuten lassen  ...
    (Date:7/24/2014)... Inc. (NasdaqGS: ABAX ), a medical products ... results for the first fiscal quarter ended June 30, ... of $47.5 million, up 10% over last year,s comparable ... over last year,s comparable quarter. Revenues highlights: ... 20% over last year,s comparable quarter. , Veterinary ...
    (Date:7/24/2014)... OAKS, Calif. , July 24, 2014 Amgen ... report its second quarter financial results on Tuesday, July 29, ... announcement will be followed by a conference call with the ... from Amgen will be Robert A. Bradway , chairman ... management team. Live audio of the conference call ...
    Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
    (Date:7/27/2014)... (HEV) transmission by blood components indicates that about 1 ... plasma. The findings, published in The Lancet , ... cells, platelets, and fresh frozen plasma) are likely to ... study retrospectively screened 225 000 individual blood donations collected ... 2013 for HEV RNA. 79 donors were found to ...
    (Date:7/27/2014)... (PRWEB) July 27, 2014 The inaugural ... Latinos demonstrate their passion for protecting our environment and ... in the Southwest, will go on hiking or camping ... to show their support for permanently protecting our land, ... sharing the Latino community’s perspective on the environment like ...
    (Date:7/27/2014)... North American security and surveillance radar market under defense ... it is expected to reach $2030 million by 2019 ... factors that influence a country’s expenditure on radars. It ... expenditure. The report also throws light on the leading ... overview of the companies, it focuses on their financial ...
    (Date:7/27/2014)... 1-Butene is a colorless, combustible gas with ... can be manufactured either through the separation from crude ... Linear alpha olefin (alkene) 1-Butene is a versatile chemical ... important chemicals such as linear light density polyethylene (LLDP), ... 1-Butene market is extremely competitive. The market has several ...
    (Date:7/27/2014)... (PRWEB) July 27, 2014 Although ... Australia is restricted to two companies, heavy government ... IBISWorld industry analyst Spencer Little, “Demand for cigarettes ... to rising health concerns, frequent anti-smoking campaigns, increasing ... industry revenue is estimated to fall at a ...
    Breaking Medicine News(10 mins):Health News:The Lancet: 1 in 3000 blood donors in England infected with hepatitis E 2Health News:Latino Conservation Action Week Launches, Highlights Latinos’ Dedication to Protecting Our Environment 2Health News:Latino Conservation Action Week Launches, Highlights Latinos’ Dedication to Protecting Our Environment 3Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 5Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 4Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Cigarette and Tobacco Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4
    ... this week in PNAS provides a comprehensive comparative functional ... highly similar brain networks preserved across evolution. An ... Center in New York City examined patterns of connectivity ... a single structure, is actually divided into four distinct ...
    ... PITTSBURGH, Nov. 2 A drug currently under development ... help bone fractures heal more quickly after radiation exposure, ... results will be presented at 1 p.m. today during ... in Chicago. The drug, JP4-039, is a free-radical ...
    ... between diagnosis and therapy, study finds , MONDAY, Nov. 2 ... to wait between lung cancer diagnosis and treatment is influenced ... study finds. , Researchers at the University of Texas Southwestern ... cell lung cancer. , They found that factors such as ...
    ... Lung Cancer in new Video, "Waitin, Room Service" , WASHINGTON, ... Dr. Armando Lung Love will launch a new public service ... lung cancer. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ) , Dr. Lung ... will star in "Waitin, Room Service" which is being launched ...
    ... , DALLAS and TRENTON, N.J., Nov. 2 Kimberly-Clark ... leading upcycling firm TerraCycle to enhance the sustainability performance ... between K-C and TerraCycle also creates fundraising programs which ... a trusted leader in helping people improve their health, ...
    ... (Downey, Calif.) Aggressively managing patients at risk for osteoporosis ... by 25 percent, according to a Kaiser Permanente study published ... & Joint Surgery . The first step must be a ... researchers say. This study, the largest to look at ...
    Cached Medicine News:Health News:Lung Cancer Alliance Announces New National Campaign Starring Dr. Armando Lung Love 2Health News:Kimberly-Clark & TerraCycle, Inc. Partner to Reduce Waste and Help Fund Schools and Non-Profits 2Health News:Kimberly-Clark & TerraCycle, Inc. Partner to Reduce Waste and Help Fund Schools and Non-Profits 3Health News:Nation's hip fracture rate could drop 25 percent with aggressive osteoporosis prevention 2Health News:Nation's hip fracture rate could drop 25 percent with aggressive osteoporosis prevention 3
    ... first manufacturer to offer through-the-lens (TTL) ... These next generation loupes feature extremely ... design, and are multi-coated lens for ... SheerVision's proprietary SureFit system - you ...
    Easy pull-on garment's feature Rainey's exclusive Non-Slip Dome™design and adjustable Velcro© closure at neck for optimal comfort and support. Choose covered or non covered ear design....
    Facial Wrap...
    CDIs Chin Support Bandage is ideal for Submental Liposuction, Chin Implants and all other facial procedures requiring support. Adjustable Velcro® top and posterior band secures placement....
    Medicine Products: